VolgendeVolgende gids
FP8 en formaten met lage precisie
Technisch
Technische GIDS
AI Precision Dosing and Pharmacokinetics
AI precision dosing combines pharmacokinetic models, which describe how a drug is absorbed, distributed and cleared, with a patient's own characteristics and measured drug levels to recommend an individualized dose.
Op deze pagina4 minuten lezen
Overzicht
For vancomycin, Bayesian dosing software estimates each patient's clearance from one or two blood levels to target an exposure range. This approach is favored by the 2020 US consensus guideline over dosing based on trough levels alone.
Diepe duik
Pharmacokinetics summarizes a drug's behavior with a few parameters. Clearance (CL) is the volume of blood cleared of drug per unit of time. Volume of distribution (V) describes how widely the drug spreads. Half-life follows from both. For vancomycin, the exposure that best predicts efficacy is the area under the concentration-time curve over 24 hours (AUC24). At steady state, AUC24 equals the daily dose divided by clearance. In 2020, a revised consensus guideline from ASHP, IDSA, PIDS and SIDP recommended AUC-guided dosing for serious MRSA infections. It set a target AUC/MIC of 400 to 600, assuming an MIC of 1 mg/L, and preferred Bayesian software. This replaced the older practice of aiming for troughs of 15 to 20 mg/L. The change was made because trough levels predict AUC poorly and high troughs were linked to kidney injury. Older methods used nomograms or first-order equations with two levels drawn at steady state within the same dosing interval. Bayesian methods start from a population model developed in published studies, which gives typical parameter values, how they change with weight, kidney function and age, and how much patients vary. The software then updates those values with the patient's measured levels. It can work with a single level, with levels not at steady state, and with irregular dosing. Commercial examples include DoseMeRx, InsightRx and PrecisePK. A common misconception is that these tools are mysterious AI. Most are built on established pharmacometric methods, known as model-informed precision dosing. Machine learning is now being added for choosing or averaging models and for predicting clearance from EHR data. Another misconception is that software removes the need for judgment. If a patient differs sharply from the population used to build the model, for example with extreme obesity, dialysis or rapidly changing kidney function, the model's starting assumptions may mislead.
Strategische impact
Kosten en budget
Architectuurbeslissingen bepalen jarenlang de prestaties en bedrijfskosten.
Duidelijkere beslissingen
Technisch onderwijs helpt teams bij het kiezen van de juiste stapel, niet alleen de nieuwste.
Kwaliteitscontrole
Betere technische keuzes verminderen het aantal betrouwbaarheidsincidenten in de productie.
The Future of AI Precision Dosing and Pharmacokinetics
Model-informed precision dosing is spreading beyond vancomycin and aminoglycosides to other drugs whose exposure varies widely between patients, such as some beta-lactams, anticancer agents and biologics. Faster drug-level assays and EHR integration are key requirements. Machine learning may help most in choosing the right model for patients outside the populations the models were built on, but it needs validation that it predicts future levels well. Adoption will depend on workflow, assay access, reimbursement and outcome studies. Evidence of better clinical outcomes, not just better target attainment, is still being developed for many drugs.
Implementatie in de echte wereld
For a patient with MRSA bacteremia, a pharmacist enters vancomycin dose times and two measured levels. The software estimates a 24-hour AUC of about 720 mg·h/L and suggests a lower dose to bring exposure into the 400 to 600 range.
Before any levels are drawn, the software uses a population model with the patient's weight and estimated kidney function to propose a loading dose and a first maintenance regimen.
For a patient with cystic fibrosis, whose aminoglycoside clearance often differs from typical adults, Bayesian estimation from measured levels guides tobramycin dosing.
In a transplant center, busulfan exposure is estimated from blood samples after an early dose, and later doses are adjusted to reach a target exposure.
Risico's en vangrails
Het optimaliseren van één benchmark kan bredere systeemzwakheden verbergen.
Infrastructuur- en onderhoudskosten worden vaak onderschat.
De lacunes op het gebied van beveiliging en waarneembaarheid kunnen groter worden naarmate systemen complexer worden.
Implementatie routekaart
Definieer latentie-, kwaliteits- en kostendoelen vóór implementatie.
Benchmark onder realistische belasting- en gegevensomstandigheden.
Instrumentbewaking op fouten, drift en gebruikersimpact.
Bereid rollback- en incidentresponspaden voor voordat u gaat schalen.
Blijf verkennen
Free newsletter
Get the daily AI briefing
Three verified AI stories every weekday morning, written in plain English. Free forever, no ads.
One email each weekday. Unsubscribe in one click. We never sell or share your address.
Test yourself
Take the AI Precision Dosing and Pharmacokinetics quiz
Instant feedback on every answer, and a shareable certificate with a verifiable ID once you pass a course.
Support free AI education. AI Understanding is a 501(c)(3) nonprofit — no ads, no paywall, ever. Make a donation
Veelgestelde vragen
What is AI Precision Dosing and Pharmacokinetics?
AI precision dosing combines pharmacokinetic models, which describe how a drug is absorbed, distributed and cleared, with a patient's own characteristics and measured drug levels to recommend an individualized dose. For vancomycin, Bayesian dosing software estimates each patient's clearance from one or two blood levels to target an exposure range. This approach is favored by the 2020 US consensus guideline over dosing based on trough levels alone.
Welk AUC/MIC-bereik beoogde de consensusrichtlijn van vancomycine uit 2020 voor ernstige MRSA-infecties, uitgaande van een MIC van 1 mg/l?
De richtlijn adviseerde een AUC/MIC van 400 tot 600, ter vervanging van de daldoelstellingen van 15 tot 20 mg/l.
Hoe is bij steady state de AUC24 van vancomycine gerelateerd aan dosis en klaring?
Bij steady-state is de totale blootstelling gedurende 24 uur gelijk aan de dagelijkse dosis gedeeld door de klaring. Daarom is het schatten van de klaring van cruciaal belang bij de dosering.
Waarom is de begeleiding afgeweken van de dosering van alleen dal vancomycine?
De gids legt uit dat dalen een imperfecte vervanging vormen voor de AUC, en dat agressieve daldoelen in verband werden gebracht met nefrotoxiciteit.
Welk voordeel hebben Bayesiaanse methoden ten opzichte van traditionele steady-state berekeningen op twee niveaus?
Omdat ze uitgaan van een populatiemodel, kunnen Bayesiaanse methoden doses individualiseren op basis van schaarse, onregelmatige gegevens.
Wat doet de strafterm, gewogen op basis van de variabiliteit tussen proefpersonen, bij een MAP-schatting?
De voorafgaande term houdt schattingen in de buurt van populatiewaarden, tenzij de gegevens van de patiënt iets anders sterk ondersteunen.
Blijf leren
Gerelateerde gidsen
Er zijn meer handleidingen voor dit onderwerp geselecteerd